Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study-Reference-Cited by-同舟云学术

Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study

Published:2013-09-16 Issue:1 Volume:67 Page:26-32
ISSN:0021-9746
Container-title:Journal of Clinical Pathology
language:en
Short-container-title:J Clin Pathol

Author:

Prins M J D,Ruurda J P,van Diest P J,van Hillegersberg R,ten Kate F J W

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference13 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010

2. HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization;Moelans;Cell Oncol,2009

3. The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study;Prins;Ann Oncol,2013

4. Assessment of a HER2 scoring system for gastric cancer: results from a validation study;Hofmann;Histopathology,2008

5. HER2 testing in gastric cancer: a practical approach;Ruschoff;Mod Pathol,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review on Computational In-Situ Hybridization (Ish) Digital Pathology Using Image Analysis Techniques: Principles and Applications;2024

2. Applications of Artificial Intelligence in Breast Pathology;ARCH PATHOL LAB MED;2023

3. Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images;Scientific Reports;2023-06-16

4. Constructing high-density tissue microarrays with a novel method and a self-made tissue-arraying instrument;Pathology - Research and Practice;2023-05

5. European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development;Toxicologic Pathology;2023-04